An employee at one of Takeda’s locations in Germany.
Keystone/Silas Stein
The Japanese pharmaceutical company Takeda has announced a reduction of up to 120 jobs at its site in Opfikon. The statutory consultation process is currently underway.
A Takeda spokesperson confirmed a report published in the Neue Zürcher Zeitung paper on Friday. The background to the planned redundancies is a company-wide, multi-year efficiency programme.
Takeda has informed its approximately 1,200 employees at the Opfikon site about the plans, the spokesperson added. The consultation process with employee representatives is currently underway. It should be finalised in the second half of June.
According to the company, the sales organisation for Switzerland, which is also based in Opfikon, and the production site in Neuchâtel are not affected by the job cuts.
+ Read more: Pharma: Novartis announces job cuts in the development division
The company announced the savings programme on May 9 when it presented its annual results. The aim of the programme is to position the company optimally for future growth. According to the company, it currently has several projects in the late stages of development.
The Takeda pharmaceutical group develops and produces medicinal products. The company employs more than 50,000 people in over 70 countries.
Adapted from German by DeepL/kc
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content